Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001654954-21-010887)

Filing Details

Accession Number:: 0001654954-21-010887
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-10-07 14:47:17
Reporting Period:: 2020-11-16

Accepted Time:: 2021-10-07 14:47:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
109657	Gt Biopharma Inc.	GTBP	Pharmaceutical Preparations (2834)	941620407

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1364846	Bruce Wendel	C/O Gt Biopharma, Inc. 9350 Wilshire Blvd. Ste. 203 Beverly Hills CA 900212		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-11-16	3,268	$3.14	3,268	No	4	P	Direct
Common Stock	Acquisiton	2020-12-22	1,374	$8.87	4,642	No	4	P	Direct
Common Stock	Acquisiton	2020-12-22	441	$8.73	5,083	No	4	P	Direct
Common Stock	Acquisiton	2021-02-16	347,572	$0.00	352,655	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	A	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option to purchase Common Stock	Acquisiton	2021-02-16	50,000	$0.00	50,000	$6.33

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
50,000		2031-02-15	No	4	A	Direct

Footnotes

Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on November 11 2020, 2021 and 2022.
1/3rd of the shares vest on February 16, 2021, 2022, and 2023.